The status of PLAU is also the biomarker of prognostic and predictive factor in breast cancer and non-small cell lung cancer37, 38 and synthetic antibody against PLAU has been demonstrated the inhibition ability to the cancer progression39. This evidence concerns the gene PLAU and cancer.